Introduction
============

The emergence of human pathogenic microorganisms that are resistant to major classes of antibiotics has increased in recent years, due to the indiscriminate use of antimicrobial drugs.^[@B1]^ This has caused many clinical problems in the treatment of infectious diseases, and the antibiotics commonly used are sometimes associated with adverse effects such as hypersensitivity, allergic reaction and immunosuppression in the host.^[@B2]^ Thus, the search for the discovery of new antimicrobial agents is an urgent need. Cameroonian traditional medicine is increasingly solicited through tradipractitioners and herbalists in the treatments of infectious diseases. On the other hand, about 80% of citizens in developing countries use traditional medicine based on plant products.^[@B3]^ Traditionally, dry herbs are used either boiled in water like tea or as an infusion to treat systemic bacterial and fungal infections, or are directly applied on the skin or nails in a plaster form to treat local infections.^[@B4]^

Some species of the Acanthaceae family present antimicrobial activities.^[@B5]^ Previous chemical studies with species of this family were related to the isolation of alkaloids, iridoids, lignans, flavonoids, terpenoids and phenylpropanoids glycosides.^[@B6]^ *Brillantaisia lamium*(Nees) Benth is an erect branched herb from Acanthaceae family, which has a height of about and is found in moist tropical areas growing both in full sun and partial shade.^[@B7]^ The aerial part of this plant is used in Cameroon in the treatment of various microbial infections such as skin diseases and infections of urinary tract. However, no phytochemical and biological studies have been reported on *B. lamium*. As a continuation of our chemical and biological studies of Cameroonian medicinal plants,^[@B8]-[@B13]^ we have investigated the CH~2~Cl~2~: MeOH (1:1) extract of the aerial part of *B. lamium*, and have reported herein the isolation of a mixture of three sterols and four pure compounds together with their antibacterial and antifungal activities.

Materials and Methods
=====================

*Plant Material*

The aerial parts of *B. lamium* Benth, were collected in January Korup, South-west region of ([figure 1](#F1){ref-type="fig"}). The botanical identification of the plant was done at the National Herbarium, , (voucher specimen No. 34376/HNC). The plant material was air-dried at room temperature and ground into fine powder.

![Aerial parts of Brillantaisia lamium](IJMS-36-24-g001){#F1}

*Microorganisms*

The test microorganisms included three bacteria and two fungi. They were mostly reference strains obtained from the American Type Culture Collection (ATCC, ): *Staphylococcus aureus* ATCC25922,*Enterococcus faecalis* ATCC10541, *Salmonella* *typhi*ATCC6539, *Candida* *albicans* ATCC9002 and *Candida* *tropicalis* ATCC750. Also included, were one clinical isolate of *Proteus* *mirabilis* and one strain of *Cryptococcus neoformans* IP95026 collected from Pasteur Institute of Yaoundé () and Paris () respectively. They were maintained at +4°C on Agar slants in the Laboratory of Microbiology and Antimicrobial Substances (LAMAS) of the Faculty of Sciences, , where the antimicrobial tests were performed. The strains were subcultured on fresh appropriate agar plate 24 hours prior to any antimicrobial test.

*Extraction, Fractionation and Isolation of Compounds*

Previously dried and powdered aerial parts of*B. lamium* () were macerated with CH~2~Cl~2~: MeOH (1:1 v/v) (3 × , 72 hours) at room temperature (25±1°C) to obtain a crude extract () after evaporation of solvent under reduced pressure at 40°C. One hundred and seventy nine grams () of this extract were successively extracted with *n-*hexane (), followed by CH~2~Cl~2~(). Thin layer chromatography (TLC) analysis showed that the *n-*hexane and CH~2~Cl~2~ extracts were qualitatively the same. They were thus combined and a portion of was subjected to silica gel column chromatography (*Ø* x *L* ) and eluted with *n*-hexane-EtOAc (10:0, 9:1, 8:2, 7:3, 1:1 and 0:10 each ) and EtOAc-MeOH (10:0, 19:1, 9:1 and 0:10 each ). Fifty five fractions of 300 ml each were collected and combined on the basis of TLC profile to give five major fractions A - E (A: 1--12; B: 13--25; C: 26--38; D: 39--45; E: 46--55). Fraction A () contained mostly fatty material and was not further investigated. Fraction B () was purified on a silica gel column (*Ø* × *L* ) with *n*-hexane-EtOAc (10:0, 90:10 and 9:1 each ) to afford lupeol (2) (20 mg; Rf=0.60, *n*-hexane-EtOAc, 9:1) and a mixture of campesterol (5), stigmasterol (6) and β-sitosterol (7) (22 mg; Rf=0.53, *n*-hexane-EtOAc, 9:1) in an estimated proportion of 1:4:1.50 (GC-MS). Fraction C () was subjected to silica gel column chromatography (*Ø* × *L* ) eluted with *n*-hexane-EtOAc (10:0, 9:1, 4:1, 3:2, 2:3 and 0:10, each ) to yield aurantiamide acetate (1) (30 mg; Rf=0.46, *n*-hexane-EtOAc, 7:3). Fraction D crystallized in methanol to give sitosterol 3-O-β-D-glucopyranoside (4) (160 mg; Rf=0.70, CH~2~Cl~2~-MeOH, 9:1). Fraction E () was submitted to silica gel column chromatography and eluted with CH~2~Cl~2~:MeOH (19:1, 17:3, 4:1, 7:3, each ) followed by purification through Sephadex LH-20 gel column chromatography using CH~2~Cl~2~:MeOH (1:1) to yield lespedin (3) (21 mg, Rf=0.35, CH~2~Cl~2~-MeOH, 9:1).

*Identification of isolated compounds*

The structural identification of compounds 1-4 was established using spectroscopic analysis, especially, NMR spectra in conjunction with 2D experiments and direct comparison with published information,^[@B6],[@B11],[@B14],[@B15]^ and authentic specimens obtained in our laboratory for some cases. Melting points of isolated compounds were uncorrected and determined on a Büchi SMP-20 melting point apparatus and with a Reichert microscope. Infra-red spectra were measured on a Shimadzu FTIR-8400S spectrophotometer and the UV spectra were recorded with a Shimadzu UV-3101 PC, spectrophotometer. Electron impact-mass spectrometry (ionization voltage 70 eV) and High resolution-electron impact-mass spectrometry spectra were measured with a Finnigan MAT double focusing spectrometer Model 8230.^[@B1]^ H-NMR (500 MHz) and,^[@B5]^ C-NMR (125 MHz) spectra were recorded in CDCl~3~ using a Bruker-Avance-500 MHz NMR spectrometer and Trimethylsilyl as internal standard. The mixture of sterols was only identified by gas chromatography-mass spectrometry. Gas chromatography-mass spectrometry (GC-MS) data were obtained with an Agilent 6890N Network GC system/5975 Inert X L Mass Selective Detector at 70 eV and 20°C. The GC column was a CP- Sil 8 CB LB, fused silica capillary column ( × , film thickness 0.25 µm). The initial temperature was 50°C for 1 min, and then heated at 10°C/min to 300°C. For the carrier gas, helium was used with a flow rate of 1.20 ml/min. Kovat's retention index (KI) was determined using a calibration curve of n-alkanes.

*Antimicrobial Assays*

*Determination of Diameters of Inhibition Zones*

The diameters of inhibition zones were determined by disc diffusion method as described by Tamokou and co-workers,^[@B10]^ with some modifications. Stock solutions of test samples were prepared in 10% v/v aqueous dimethylsulfoxide (DMSO) solution (Fisher chemicals) at concentrations of 100 mg/ml (for crude extract and fractions) and 10 mg/ml (for pure compounds). The inocula of microorganisms were prepared from 24 h old broth cultures. The absorbance was read at 600 nm and adjusted with sterile physiological solution to match that of a 0.5 McFarland standard solution. From the prepared microbial solutions, other dilutions with sterile physiological solution were prepared to give a final concentration of 10^6^ colony-forming units (CFU) per milliliter for bacteria and 2x10^5^ spores per milliliter for yeasts. Bottles containing 19.80 ml of sterile molten Sabouraud Dextrose Agar (, , ) or Mueller Hinton Agar (MHA) () were maintained in a water bath at 45°C to prevent solidification of the medium, and were aseptically inoculated with 200 µl of bacteria or yeast suspension. Microbial inoculum and medium were well mixed and dispensed into sterile diameter Petri dishes and allowed to solidify at room temperature in a sterile cupboard. After solidification, discs of in diameter previously impregnated with 10 µl of test samples were placed aseptically on the solid plates. This gave a charge of 1 mg or 100 µg of test substances per disc. The Petri dishes were left at +4°C for 2 h to allow extracts and compounds to diffuse from the discs into the medium. The test media were then incubated at 35°C for 24 h (for bacteria) and 48 h (for yeasts). Antimicrobial activity was evaluated by measuring the clear zone of growth inhibition on agar surface around the discs. The assay was done in triplicates. Gentamicin (Sigma-Aldrich, , ) and nystatin (Merck, ) were used as positive controls for bacteria and yeasts respectively at 10 µg per disc. Dimethylsulfoxide solution (10% v/v) was used as a negative control.

*Determination of minimum inhibitory concentrations (MICs) and minimum microbicidal concentrations (MMCs)*

Minimum inhibitory concentration values were determined by broth micro dilution method as reported by Nyaa and co-workers.^[@B16]^ The test samples were first of all dissolved in DMSO. The solution obtained was then added to Mueller Hinton Broth (MHB) for bacteria or Sabouraud Dextrose Broth (SDB) for yeasts to give a final concentration of 2000 µg/ml. This was serially diluted two folds to obtain a concentration range of 0.48 to 2000 µg/ml. One hundred microliters of each concentration was added into each well (96- wells microplate) containing 95 µl of MHB or SDB and 5 µl of inoculum (10^6^ CFU/ml for bacteria and 5x10^5^ spores/ml for yeasts) to obtain final concentrations varying from 0.12 to 1000µg/ml. The final concentration of DMSO in the well was less than 1% (v/v). Preliminary analysis with 1% (v/v) DMSO did not inhibit the growth of the test organisms. The negative control wells consisted of 195 µl of MHB or SDB and 5 µl of the inoculum. The plates were covered with sterile lids, then agitated to mix the contents of wells using a plate shaker and incubated at 35°C for 24 hours for bacteria, 48 hours for *Candida sp*, or 72 hours for *Cryptococcus neoformans*. The assays were repeated thrice. The MICs of samples were detected following the addition of 50 µl of a 0.20 mg/ml *p*-iodonitrotetrazolium violet (INT) solution followed by incubation at 35°C for 30 min. The colorless tetrazolium salt acts as an electron acceptor and is reduced to a red-colored formazan product by biologically active microorganisms. Where microbial growth was inhibited, the solution in the well remained clear after incubation with INT. Minimum inhibitory concentrations were defined as the lowest sample concentrations that prevented this color change indicating a complete inhibition of microbial growth.

###### 

Diameters (mean±SD) of inhibition zones of the CH~2~Cl~2~: MeOH (1:1) extract and fractions and compounds isolated from *Brillantaisia lamium*

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Test**\            **Diameters of inhibition zones (in mm)**                                                                                    
  **substances**                                                                                                                                    
  -------------------- ------------------------------------------- --------------- --------------- --------------- ---------------- --------------- ----------------
  Crude extract        20.00±0.50^b^                               18.00±1.0^a^    21.00±0.50^a^   20.00±0.00^a^   15.00±0.00^b^    17.50±1.00^a^   15.50±1.00^a^

  Fraction A           na                                          na              na              na              na               na              na

  Fraction B           14.50±1.0^a^                                16.00±0.00^b^   na              na              na               15.00±0.00^b^   na

  Fraction C           17.50±0.50^c^                               15.00±0.50^c^   na              na              13.50±1.00^a^    14.50±0.50^b^   12.50±1.00^d^

  Fraction D           21.00±0.50^b^                               22.50±0.50^d^   23.50±0.50^d^   24.00±0.00^e^   17.50±0.50^c^    20.00±1.0^c^    18.00±0.00^b^

  Fraction E           na                                          12.50±0.50^e^   na              na              11.00±0.50^d^    14.50±0.50^b^   na

  Mixture of sterols   14.50±0.50^a^                               13.00±0.00^e^   na              12.50±0.50^b^   na               11.00±0.00^d^   na

  1                    11.0 0± 0.00^d^                             16.00±0.00^b^   13.00±0.50^b^   15.00±0.00^c^   15.50 ±0.50^b^   13.00±0.00^e^   17.0 0±0.50^c^

  2                    10.00±0.00^e^                               12.50±1.00^e^   na              12.00±0.00^b^   11.50±0.50^d^    na              12.50±1.00^d^

  3                    20.50±0.50^b^                               26.50±0.50^f^   26.00±0.00^c^   23.50±1.00^e^   15.50 ±0.50^b^   15.00±0.00^b^   18.00±0.50^b^

  4                    11.50±0.00^d^                               13.50±0.50^e^   na              14.50±0.50^c^   13.00±0.00^a^    15.00±0.50^b^   15.00±1.00^a^

  Gentamicin           20.50±1.50^b^                               25.50±1.00^f^   24.00±0.50^d^   19.00±0.00^d^   nt               nt              nt

  Nystatin             nt                                          nt              nt              nt              25.50±0.50^e^    22.00±1.00^c^   26.00±0.50^f^
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

Zone diameters were determined at 1 mg (for the crude extract and fractions), 100 µg (for the isolated compounds and mixture of sterol) or 10 µg (for gentamicin and nystatin) per spot; 1 mg, 100 µg and 10 µg were the minimum charges of a disc. For the same column, mean diameters of inhibition zones of the test samples bearing different superscript letters (a, b, c, d, e, f) are significantly different (p\<0.05) compared to other mean values, and those carrying the same superscripts are not significantly different. The results are the mean values of triplicate tests measured in two directions after 24-48 h incubation at 35 °C.; na: not active; nt: not tested; aurantiamide acetate (1); lupeol (2); lespedin (3); sitosterol 3-O-β-D-glucopyranoside (4); a mixture of sterols: campesterol (5); stigmasterol (6); β-sitosterol (7)

For the determination of MMCs, a portion of liquid (5 µl) from each well that showed no growth of microorganism was plated on MHA or SDA and incubated at 35°C for 24 hours for bacteria, 48 hours for *Candida sp*, or 72 hours for *Cryptococcus neoformans*. The lowest concentration that yielded no revival of growth after this subculturing was taken as the MMCs.^[@B16]^ Gentamicin and nystatin were used as positive controls for bacteria and yeasts respectively.

*Statistical Analysis*

Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) for Window software version 12.0. The inhibition diameters of test substances were expressed as meanstandard deviation. Group comparisons were done using one way analysis of variance (ANOVA) followed by Waller-Duncan Post Hoc test. A value of P\<0.05 was considered statistically significant.

Results
=======

Four known compounds: aurantiamide acetate (1), lupeol (2), lespedin (3), sitosterol 3-O-β-D-glucopyranoside (4) and a mixture of sterols: campesterol (5), stigmasterol (6) and β-sitosterol (7) were isolated from CH~2~Cl~2~: MeOH (1:1) extract of *B. lamium* aerial parts ([figure 2](#F2){ref-type="fig"}).

![Chemical structures of aurantiamide acetate (1), lupeol (2), lespedin (3), sitosterol 3-O-β-D-glucopyranoside (4), a mixture of sterols: campesterol (5), stigmasterol (6) and β-sitosterol (7) isolated from *B. lamium*.](IJMS-36-24-g002){#F2}

The results of the antimicrobial activity showed that the CH~2~Cl2: MeOH (1:1) extract, fractions B-E and all the isolated compounds showed both antifungal and antibacterial activities that varied among the microbial strains ([tables 1](#T1){ref-type="table"}-3). Gram-positive bacteria were more sensitive to the test samples as compared with Gram-negative bacteria ([table 1](#T1){ref-type="table"}). Fraction A was found to be not active, and *Salmonella typhi* and *Candida albicans* were respectively the most resistant strains for bacteria and yeasts against all the tried samples. Fractionation enhanced the antimicrobial activity of the crude extract in fraction D (MIC=62.50-125 µg/ml). However, these activities decreased in other fractions. The results of MIC and MMC values were in agreement with the above observations ([tables 2](#T2){ref-type="table"}-[3](#T3){ref-type="table"}). The antimicrobial activity of compound 1 (MIC=50-200 µg/ml) was almost found to be comparable to that of gentamicin (MIC=12.50-100 µg/ml), but lower than that of nystatin (MIC=1.56-6.25 µg/ml) ([table 2](#T2){ref-type="table"}). Compound 3 (MIC=6.25-25 µg/ml) was the most active substance among the test samples (MIC=12.50-400 µg/ml). Moreover, its antibacterial activity was higher than that of gentamicin (MIC=12.50-100 µg/ml), which was used as a reference drug.

Discussion
==========

The findings of the present study showed that there were differences between the antimicrobial activities of crude extract and those of fractions. This suggests that the aerial part of *B. lamium* contains several antifungal and antibacterial principles with different polarities as shown by the phytochemical study. The fractionation of the crude extract enhanced its antimicrobial activity in fraction D, and reduced those of other fractions. This indicates that the active principles might be more concentrated in fraction D and more diluted in other fractions. All the isolated compounds showed antimicrobial activities on at least one microorganism. Such a finding supports the traditional use of this plant in the treatment of infectious diseases. The antimicrobial properties of some individual flavonoids, sterols and triterpenes of plant origin were documented.^[@B9],[@B16]-1[@B9]^ Compounds 1 and 2 displayed antibacterial as well as antifungal activities. Comparable results were obtained by Ragasa et al.^[@B19]^ and Singh and Singh.^[@B20]^

###### 

Minimum inhibitory concentrations (MIC) of the CH~2~Cl~2~: MeOH (1:1) extract, fractions and compounds of *Brillantaisia lamium*

  **Test substances**   **Minimum inhibitory concentrations (in µg/ml)**                                         
  --------------------- -------------------------------------------------- ------ ------- ------- ------ ------- -------
  Crude extract         125                                                250    125     62.50   500    250     250
  Fraction A            na                                                 na     na      na      na     na      na
  Fraction B            1000                                               500    na      na      na     500     na
  Fraction C            250                                                500    na      na      1000   500     1000
  Fraction D            125                                                125    62.50   62.50   125    62.50   125
  Fraction E            na                                                 500    na      na      1000   500     na
  Mixture of sterols    50                                                 100    na      200     na     400     na
  1                     100                                                50     50      100     50     100     12.50
  2                     400                                                200    na      200     200    na      200
  3                     25                                                 6.25   12.50   12.50   50     50      6.25
  4                     100                                                100    na      100     200    100     50
  Gentamicin            12.50                                              50     50      100     nt     nt      nt
  Nystatin              nt                                                 nt     nt      nt      1.56   6.25    1.56

Tabulated values are the means of three trials which did not show any variation (SD=0); na: not active at concentrations up to 400 µg/ml (for pure compounds and mixture of sterols) or 1 mg/ml (for crude extract and fractions); nt: not tested; gentamycin and nystatin are used as reference antibiotics for bacteria and yeasts respectively; aurantiamide acetate (1); lupeol (2); lespedin (3); sitosterol 3-O-β-D-glucopyranoside (4); a mixture of sterols: campesterol (5); stigmasterol (6); β-sitosterol (7).

###### 

Minimum microbicidal concentrations (MMC) of the CH~2~Cl~2~: MeOH (1:1) extract, fractions and compounds of *Brillantaisia lamium*

  **Test substances**   **Minimum microbicidal concentrations (in µg/ml)**                                         
  --------------------- ---------------------------------------------------- ------- ------- ------- ------ ------ -------
  Crude extract         250                                                  250     250     125     500    500    250
  Fraction A            na                                                   na      na      na      na     na     na
  Fraction B            1000                                                 500     na      na      na     1000   na
  Fraction C            500                                                  500     na      na      1000   1000   1000
  Fraction D            125                                                  250     125     62.50   250    125    125
  Fraction E            na                                                   500     na      na      1000   500    na
  Mixture of sterols    100                                                  100     na      200     na     400    na
  1                     100                                                  50      50      100     50     100    25
  2                     400                                                  200     na      200     200    na     200
  3                     25                                                   12.50   12.50   25      100    50     12.50
  4                     200                                                  100     na      100     200    200    100
  Gentamicin            12.50                                                50      50      100     nt     nt     nt

Tabulated values are the means of three trials which did not show any variation (SD=0); na: not active at concentrations up to 400 µg/ml (for pure compounds and mixture of sterols) or 1 mg/ml (for crude extract and fractions); nt: not tested; gentamycin and nystatin are used as reference antibiotics for bacteria and yeasts respectively; aurantiamide acetate (1); lupeol (2); lespedin (3); sitosterol 3-O-β-D-glucopyranoside (4); a mixture of sterols: campesterol (5); stigmasterol (6); β-sitosterol (7).

The known antimicrobial mechanisms associated to each group of chemicals to which the isolated compounds belong may explain the antimicrobial potency of the crude extract, fractions and compounds from *B. lamium*. Membrane disruption has been suggested as one of the likely mechanisms of action.^[@B21],[@B22]^ This might also explain the antimicrobial activities of compounds 2 (triterpene), 4, 5, 6 and 7 (sterols).^[@B21],[@B22]^ The activity of flavonoids such as compound 3 might be due to their ability to complex with bacteria cell wall,^[@B21]^ and therefore, inhibiting the microbial growth.

The antimicrobial activities varied with the bacterial and fungal species. These variations may be due to genetic differences between the microorganisms. The results of MMC values ([table 3](#T3){ref-type="table"}) indicated that a cidal effect of many of the tried samples could be expected. Moreover, a keen look at the results of MIC ([table 2](#T2){ref-type="table"}) and MMC ([table 3](#T3){ref-type="table"}), showed that the MIC values obtained were four times lesser than the MMCs on the corresponding (sensitive) microorganisms, confirming the microbicidal effects of the concerned samples.^[@B9],[@B23]^ This is interesting in view of the perspective of developing new antibacterial drugs from natural products. To the best of our knowledge, this is the first report on the antimicrobial activities of the crude extract, fractions and compounds from *B. lamium.*

The overall results of this study can be considered as very promising in the perspective of new drugs discovery from plant sources, especially when the medical importance of tested microorganisms is considered. *Staphylococcus aureus* is a major cause of community and hospital-associated infection with an estimated mortality of around 7-10%.^[@B24]^ Moreover, about 2% of patients in Cameroon, are infected by *Staphylococcus*spp.^[@B25]^ Each year, some 500,000 patients in American hospitals contract a staphylococcal infection.^[@B24]^ Such findings stress the importance of finding an antibiotic against which the organism (*Staphylococcus aureus*) is sensitive. This pathogen was found to be sensitive to the crude extract, fractions and isolated compounds.

About 77% of immune-deficient patients\' death is attributable to microscopic fungi, such as *Candida*species and *Cryptococcus neoformans*.^[@B26]^ Also, 75% of women, during their lives, would have had at least one episode of vulvo-vaginitis candidiasis, which is considered as the second most common form of vaginitis after bacterial vaginosis.^[@B27]^ Typhoid fever caused by *Salmonella typhi* continues to be a significant public health problem in developing countries in general and in Sub-Saharan Africa in particular. Generally, at least three of the samples tested (i.e. Fraction D, compounds 1 and 3) in this study prevented the growth of all microbial strains.

Conclusion
==========

The results of this study indicate that the CH~2~Cl~2~: MeOH (1:1) extract from aerial parts of *B. lamium* might represents a potential source of plant drugs for the treatment of fungal and bacterial diseases. Also, all the isolated compounds found active in this study could be useful for the development of new antimicrobial drugs. However, pharmacological and toxicological studies, currently going on in our laboratory, will be necessary to confirm this hypothesis.

This research was supported by the International Sciences Program, Uppsala University, Sweden (ISP, Grant No CAM: 02, to Prof Tane), the International Foundation for Science, Stockholm, Sweden, and the Organization for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS-OPCW, Grant No F/ 4238-1, to Dr Tene). We thank Pr. Karsten Krohn, Department of Chemistry, , and Pr. SF Kouam of \"Ecole Normale Supérieure de Yaoundé\", University of Yaounde 1, Cameroon for the NMR spectra analyses.

**Conflict of Interest:** None declared
